证券代码：002102 证券简称：能特科技 公告编号：2025-074 本次交易已经公司 2025 年 4 月 24 日召开的第七届董事会第三十一次会议审 议通过，无需获得股东大会的批准。公司董事会同意授权公司管理层按照《企业国 有资产交易监督管理办法》《企业国有资产交易操作规则》等相关法律法规的规定 办理公开挂牌转让燊乾矿业 100%股权的具体事宜。如未能征集到符合条件的交易 对手方或最终未能成交，具体由公司董事会及董事会授权人根据市场情况及公司 实际情况决定。具体内容详见公司于 2025 年 4 月 26 日、2025 年 6 月 6 日、2025 年 6 月 14 日披露的《关于公开挂牌转让全资子公司陕西省安康燊乾矿业有限公司 湖北能特科技股份有限公司 关于公开挂牌转让全资子公司 陕西省安康燊乾矿业有限公司 100%股权的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 湖北能特科技股份有限公司（以下简称"公司"）在武汉光谷联合产权交易所 荆州产权交易有限公司（以下简称"荆州产交所"）公开挂牌转让公司之全资子公 司陕西省安康燊乾矿业有 ...

Group 1 - Shengde Xintai won a bid for a thermal power steel pipe project worth approximately 217 million yuan, accounting for 8.15% of its audited revenue for 2024 [1] - High-speed Electric's subsidiary won a project for the Shanghai-Nanjing-Hefei high-speed railway, with a bid amount of 71.76 million yuan [1] - Cangge Mining's subsidiary received a construction permit for a lithium-boron mining project, with a construction area of 106,900 square meters [2] Group 2 - China Electric Power Construction signed a mining transportation project contract in Guinea worth approximately 5.063 billion yuan, with a total duration of about 72 months [3] - Guobang Pharmaceutical's subsidiary completed the registration of an equity investment fund focusing on strategic emerging industries [4] - Deshi Co. obtained two invention patents related to oil and gas field development [5][26] Group 3 - Xue Tian Salt Industry expects a significant decrease in net profit for the first half of 2025, projecting a decline of 76.34% to 80.29% [6] - Rundu Co. received a drug registration certificate for moxifloxacin hydrochloride tablets, used for treating various bacterial infections [7] - China Nuclear Power reported a 15.65% increase in power generation in the first half of the year, with nuclear power generation up by 12.01% [8] Group 4 - Suqian Liansheng obtained two invention patents related to wastewater treatment methods [9] - Boshi Co. signed a 109 million yuan operation and maintenance service contract for solid product packaging [11] - *ST Sailong's subsidiary received a drug registration certificate for torasemide injection, used for various medical conditions [13] Group 5 - North Bay Port reported a 10.95% increase in cargo throughput for the first half of 2025, with container throughput also showing growth [14] - Kaiwei Te expects a revenue increase of 56.17% to 90.87% for the first half of 2025 [15] - Wankai New Materials plans to reduce production and conduct maintenance on 60,000 tons of PET capacity, affecting overall performance [16] Group 6 - Haiwang Bio's HW130 injection successfully completed Phase I clinical trials, showing good safety and tolerability [19] - Zhenai Meijia received a total of 22.8 million yuan in compensation for land acquisition, which will significantly impact its 2025 performance [20] - Changyuan Electric reported a 23.58% decrease in power generation in June, with a notable decline in thermal power generation [21] Group 7 - Shouxiangu's subsidiary completed the registration of two health food products [22] - Kailun Co. announced the resignation of its deputy general manager and board secretary [23] - Xibu Muye reported a 2.15% year-on-year increase in fresh milk production in June [24] Group 8 - Deshi Co. obtained two invention patents related to oil and gas field development [26] - Jingwei Huikai plans to acquire a 12.44% stake in Nuo Si Micro for 149 million yuan [27] - Electric Alloy completed the registration of its subsidiary in Mexico [29] Group 9 - Meinuohua expects a net profit increase of 142.84% to 174.52% for the first half of 2025 [30] - Guizhou Moutai repurchased approximately 3.38 million shares, accounting for 0.2692% of its total share capital [31][32] - Warner Pharmaceutical received approval for the listing application of a raw material drug for treating respiratory diseases [34] Group 10 - Yuan Dong Bio's independent director is under investigation for serious violations [35] - Dash Intelligent signed a contract for a smart project worth 11.88 million yuan [36] - Dayou Energy plans to transfer 586,500 tons of coal production capacity replacement indicators [37] Group 11 - Foton Motor reported a 150.96% increase in new energy vehicle sales in the first half of 2025 [39] - Renfu Pharmaceutical's shareholder plans to increase its stake by 1% to 2% [40] - Zongshen Power expects a net profit increase of 70% to 100% for the first half of 2025 [42] Group 12 - Yingboer plans to sell its wholly-owned subsidiary for 239 million yuan [44] - Changan Automobile reported a 1.59% increase in total vehicle sales in the first half of 2025 [46] - Fulian Precision signed a cooperation framework agreement with Sichuan Development Longmang [48] Group 13 - Nengte Technology plans to repurchase shares worth 300 million to 500 million yuan [50] - Longsoft Technology's controlling shareholder donated 3.43% of the company's shares [51] - Data Port's shareholders plan to reduce their holdings by up to 2% [52]

Market Performance - The hair medical concept sector rose by 2.34%, ranking 10th among concept sectors, with 19 stocks increasing in value, including JiuZhiTang which hit the daily limit, and TianEnKang, KangHui Pharmaceutical, and KangYuan Pharmaceutical which rose by 6.42%, 5.16%, and 4.55% respectively [1] - The top gainers in today's market include the fruit index at 4.73%, PCB concept at 3.27%, and AI mobile at 2.92%, while the military restructuring concept saw a decline of 1.49% [1] Capital Flow - The hair medical concept sector experienced a net inflow of 219 million yuan, with 11 stocks receiving net inflows, and 5 stocks seeing inflows exceeding 10 million yuan. JiuZhiTang led with a net inflow of 172 million yuan, followed by ShuiYang Co., KangYuan Pharmaceutical, and NengTe Technology with net inflows of 34.25 million yuan, 21.05 million yuan, and 13.44 million yuan respectively [1] - In terms of capital inflow ratios, JiuZhiTang, ShuiYang Co., and KangHui Pharmaceutical had the highest net inflow rates at 33.17%, 6.81%, and 6.15% respectively [2] Stock Performance - JiuZhiTang saw a significant increase of 10.06% with a turnover rate of 7.62%, while ShuiYang Co. and KangYuan Pharmaceutical increased by 3.12% and 4.55% respectively [2] - Stocks such as *ST JinBi and AoYang Health experienced declines of 0.69% and 0.26% respectively, indicating some volatility within the sector [1][3]

证券代码：002102 证券简称：能特科技 公告编号：2025-073 湖北能特科技股份有限公司（以下简称"公司）于 2025 年 7 月 2 日召开第 七届董事会第三十三次会议和第七届监事会第二十六次会议，审议通过了《关 于回购股份并注销的议案》，具体内容详见公司于 2025 年 7 月 3 日披露的《关 于回购股份方案的公告》（公告编号：2025-071）。 根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引 第 9 号——回购股份》等相关规定，现将董事会决议公告前一交易日（2025 年 7 月 2 日）登记在册的前十名股东和前十名无限售条件股东的名称、持股数量及 比例公告如下： 注：以上股东的持股数量为合并普通账户和融资融券信用账户后的持股数量。 1 序号 股东名称 持股数量 （股） 占总股本 比例 1 湖北荆江实业投资集团有限公司 338,463,100 12.86% 2 陈烈权 232,163,822 8.82% 3 邓海雄 178,674,857 6.79% 4 北京天宇泽华物联科技有限公司 57,550,100 2.19% 5 汕头市金塑投资咨询中心（有限合伙） 37,013,10 ...

Key Points - Jiangnan Water received a stake increase from Lianan Life Insurance, reaching 5.03% of total shares [3] - Yingboer plans to transfer 100% equity of Zhuhai Dingyuan for 239 million yuan to optimize asset structure [4] - Chengbang Co. warns that its stock price fluctuations are not aligned with its fundamentals, as it has seen five consecutive trading days of price increases [6] - Weimais intends to invest 190 million yuan into its subsidiary for a new electric drive assembly project [7] - Fosun Pharma's subsidiary received EU GMP certification for its production facilities, indicating compliance with EU standards [8] - Jingwei Huikai plans to acquire an additional 12.44% stake in Nosi Micro, increasing its control in the semiconductor sector [9] - ST Tongmai will remove its delisting risk warning starting July 4, while continuing other risk warnings [10] - ST Modern seeks to apply for the removal of other risk warnings but will maintain delisting risk warnings [11] - Luxshare Precision is planning to issue H-shares for listing on the Hong Kong Stock Exchange [12] - Hainan Highway intends to purchase a 51% stake in Hainan Jiaokong Petrochemical, which will become a subsidiary [13] - Jucheng Co. plans to transfer 1.25% of its shares through a price inquiry [14] Performance Highlights - Foton Motor reported a 150.96% year-on-year increase in new energy vehicle sales for the first half of the year [15] - Jiangling Motors achieved a total vehicle sales of 172,700 units in the first half, up 8.15% year-on-year [16] - Changan Automobile's sales reached 1.3553 million units in the first half, with new energy vehicle sales growing by 49.05% [17] - Meinuohua expects a net profit increase of 142.84% to 174.52% for the first half of the year [18] - Jihong Co. anticipates a net profit increase of 55% to 65% for the first half of the year [19] - Nanjing Business Travel expects a net profit decrease of 67.4% to 78.27% for the first half of the year [20] - Madi Technology forecasts a net profit of 25 million to 27 million yuan, marking a turnaround from losses in the previous year [21] Major Contracts - Dash Intelligent signed a contract for an intelligent project worth 11.88 million yuan [22] - Jinyi Industrial won a bid for a 335 million yuan intercity railway materials procurement project [23] - Sichuan Road and Bridge signed a construction contract worth approximately 11.596 billion yuan [24] - Fulian Precision signed a cooperation framework agreement with Chuanfa Longmang for lithium battery material projects [26] Share Buybacks - Kweichow Moutai repurchased 72,000 shares in June, totaling 1.02 billion yuan [27] - Feiwo Technology plans to repurchase shares worth 25 million to 50 million yuan [28] - Nengte Technology intends to repurchase shares worth 300 million to 500 million yuan for capital reduction [29] - CATL has repurchased 6.641 million A-shares for a total of 1.551 billion yuan [30] Shareholding Changes - Renfu Pharmaceutical's shareholder plans to increase its stake by 1% to 2% [31] - Sanwei Xinan's shareholder intends to reduce its stake by up to 2% [33] - Data Port's shareholders plan to reduce their stakes by up to 2% [34] - Zhuzhou Design's controlling shareholders plan to reduce their stakes by up to 3% [35] - Tianji Co.'s controlling shareholders plan to reduce their stakes by up to 3% [36] - Anjisi's shareholders plan to reduce their stakes by up to 4% [37] Financing Activities - CITIC Securities received approval to issue up to 20 billion yuan in perpetual subordinated bonds [39]

Core Viewpoint - Nengte Technology announced two buyback plans that could lead to the cancellation of approximately 1 billion yuan worth of shares, directly enhancing the company's per-share equity [1][4]. Group 1: Buyback Plans - The company plans to use its own and self-raised funds to repurchase A-shares, with a total budget of 300 million to 500 million yuan, at a price not exceeding 4.70 yuan per share, within 12 months from the date of shareholder meeting approval [3][5]. - All repurchased shares will be canceled, leading to a reduction in registered capital, reflecting the company's confidence in its future development and recognition of its value [4][6]. Group 2: Share Cancellation Impact - Nengte Technology intends to cancel 157 million shares previously repurchased, reducing total share capital from 2.633 billion shares to 2.476 billion shares, pending shareholder approval [6]. - The cancellation of shares will increase various per-share metrics, such as revenue per share, which will rise from 4.66 yuan to 4.96 yuan, and the price-to-sales ratio will decrease from 0.74 to 0.70 [7]. Group 3: Market Performance and Future Outlook - The previous buyback helped stabilize the stock price, which had experienced a 30% decline but rebounded nearly 12% after the buyback period ended, with a recent trading halt on July 1 [8]. - Nengte Technology is currently experiencing a recovery in performance, reporting a profit of 216 million yuan in Q1 after a loss last year, and is focused on enhancing profitability through its fine chemical business [9].

证券代码：002102 证券简称：能特科技 公告编号：2025-071 湖北能特科技股份有限公司 关于回购股份方案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或者重大遗漏。 重要内容提示： 1、湖北能特科技股份有限公司（以下简称"公司""本公司"）拟使用自 有资金及自筹资金，通过深圳证券交易所交易系统以集中竞价交易方式回购部 分公司发行的 A 股社会公众股份，本次回购股份将全部用于注销并相应减少注 册资本。本次回购股份的资金总额拟不低于人民币 30,000 万元（含），不超过 人民币 50,000 万元（含），回购价格不超过人民币 4.70 元/股（含）。本次回购 股份的实施期限为自公司股东大会审议通过回购方案之日起 12 个月内。具体回 购股份的数量以回购方案实施完毕时实际回购的股份数量为准。 2、相关股东是否存在减持计划：截至本公告披露日，公司董事、监事、高 级管理人员，控股股东、实际控制人及其一致行动人在回购期间暂无明确的增 减持计划。若未来上述主体拟实施股份增减持计划，公司将严格按照相关法律 法规的规定及时履行信息披露义务。 3、风险提示 （1）本次回购 ...

二、董事会会议审议情况 （一）以 9 票赞成、0 票反对、0 票弃权的表决结果审议批准《关于注销公 司回购股份暨减少注册资本并修订〈公司章程〉的议案》。 本议案尚需 2025 年第五次临时股东大会审议。 证券代码：002102 证券简称：能特科技 公告编号：2025-066 湖北能特科技股份有限公司 第七届董事会第三十三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 湖北能特科技股份有限公司（以下简称"公司"）第七届董事会第三十三次 会议采取通讯表决的方式于 2025 年 7 月 2 日上午召开。本次会议由公司董事长 陈烈权先生召集和主持，会议通知已于 2025 年 6 月 28 日以专人递送、电子邮件 等方式送达全体董事、监事和高级管理人员。本次会议应参加会议的董事九人（发 出表决票九张），实际参加会议的董事九人（收回有效表决票九张）。本次会议的 召集、召开符合《中华人民共和国公司法》和《公司章程》的有关规定。 《关于注销公司回购股份暨减少注册资本并修订〈公司章程〉的公告》（公 告编号： 2025-068 ） 详 见 ...

Core Viewpoint - The company plans to repurchase a portion of its publicly issued A-shares using its own and self-raised funds, with the intention of canceling the repurchased shares and reducing registered capital [1] Group 1: Repurchase Details - The total amount for the repurchase is proposed to be no less than RMB 300 million and no more than RMB 500 million [1] - The maximum repurchase price is set at RMB 4.7 per share [1] - The implementation period for the repurchase is within 12 months from the date the shareholders' meeting approves the repurchase plan [1]

证券代码：002102 证券简称：能特科技 公告编号：2025-068 湖北能特科技股份有限公司 一、回购股份实施情况概述 1、公司于 2025 年 2 月 11 日分别召开了第七届董事会第二十七次会议、第 七届监事会第二十一次会议，于 2025 年 2 月 27 日召开了 2025 年第二次临时股 东大会，审议通过了《关于回购股份并注销的议案》，同意公司使用自有资金及 自筹资金通过深圳证券交易所交易系统以集中竞价交易方式回购部分公司股份， 回购资金总额不低于人民币 30,000 万元（含），不超过人民币 50,000 万元（含）， 回购价格不超过人民币 3.90 元/股（含），实施期限为自公司股东大会审议通过 回购方案之日起 12 个月内（即 2025 年 2 月 28 日至 2026 年 2 月 27 日），具体 回购股份的数量以回购方案实施完毕时实际回购的股份数量为准。本次回购股份 将全部用于注销并相应减少注册资本。具体内容详见公司于 2025 年 3 月 5 日披 露的《回购报告书》（公告编号：2025-019）。 2、公司自 2025 年 3 月 5 日首次实施回购股份至 2025 年 6 月 27 ...